Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    50%(1 trials)

    Phase Distribution

    Phase 1/2
    1
    50%
    Not Applicable
    1
    50%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    Phase 1/2Combined phases
    1(50.0%)
    N/ANon-phased studies
    1(50.0%)

    Highest Phase Reached

    Phase 1/2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Completed(2)

    Detailed Status

    Completed2

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 1/2

    Trials by Phase

    Phase 1/21 (50.0%)
    N/A1 (50.0%)

    Trials by Status

    completed2100%

    Recent Activity

    0 active trials
    Showing 2 of 2
    completednot_applicable

    Women Veterans' Substance Abuse Treatment

    NCT00734903
    completedphase_1_2

    12-step Facilitation for the Dually Diagnosed

    NCT00583440

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT00734903Not Applicable

    Women Veterans' Substance Abuse Treatment

    Completed
    NCT00583440Phase 1/2

    12-step Facilitation for the Dually Diagnosed

    Completed

    All 2 trials loaded

    Drug Details

    Intervention Type
    Behavioral
    Total Trials
    2